0.479
4.15%
0.0191
Turnstone Biologics Corp (TSBX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-03-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | 19.31 |
Operating Expenses
|
15.88%
20.69
|
17.86 | 18.93 | 19.70 |
Operating Income/Loss |
15.88%
-20.69
|
-17.86 | -18.93 | -0.394 |
Nonoperating Income/Loss |
13.13%
1.078
|
1.241 | 1.578 | 0.38 |
Income/Loss From Continuing Operations Before Tax |
18.04%
-19.61
|
-16.61 | -17.35 | 0.068 |
Income Tax Expense/Benefit |
109.70%
0.016
|
-0.165 | -0.033 | -0.082 |
Income/Loss From Continuing Operations After Tax |
19.33%
-19.63
|
-16.45 | -17.32 | 0.068 |
Net Income/Loss
|
19.33%
-19.63
|
-16.45 | -17.32 | 0.068 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - |
Basic Average Shares |
500.48%
23.01
|
3.8322 | 17.40 | -12.51 |
Diluted Average Shares |
500.48%
23.01
|
3.8322 | 17.40 | -12.51 |
Basic Earnings Per Share |
454.17%
-0.85
|
0.24 | -1.00 | 3.54 |
Diluted Earnings Per Share |
454.17%
-0.85
|
0.24 | -1.00 | 3.54 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
자본화:
|
볼륨(24시간):